Head and Neck Cancer Trial, Recruiting (NCT06030011)

Head and Neck Cancer Trial, Recruiting NCT06030011 Sponsor: The University of Texas Health Science Center, Houston Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06030011 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

People who have been diagnosed with head and neck cancer (confirmed by a tissue sample/biopsy) and are receiving radiation treatment, with or without chemotherapy, with the goal of curing the cancer
People who speak English or Spanish

For clinicians (healthcare workers):

Healthcare professionals — such as doctors, nurses, dentists, physician assistants, social workers, nutritionists, or speech and swallowing therapists — who care for head and neck cancer patients at the hospitals or clinics taking part in this trial

Who may not be able to join:

People who have a medical condition that would make it difficult to give informed consent or complete the study questionnaires (this applies to both patients and clinicians)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Janet H. Van Cleave, PhD, RN, The University of Texas Health Science Center at Houston (UTHealth Houston)

Phone: (713) 500-2000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06030011

Sponsor: The University of Texas Health Science Center, Houston

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: (713) 500-2000

More information: https://clinicaltrials.gov/study/NCT06030011

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For patients:

People who have been diagnosed with head and neck cancer (confirmed by a tissue sample/biopsy) and are receiving radiation treatment, with or without chemotherapy, with the goal of curing the cancer
People who speak English or Spanish

For clinicians (healthcare workers):

Healthcare professionals — such as doctors, nurses, dentists, physician assistants, social workers, nutritionists, or speech and swallowing therapists — who care for head and neck cancer patients at the hospitals or clinics taking part in this trial

Who may not be able to join:

People who have a medical condition that would make it difficult to give informed consent or complete the study questionnaires (this applies to both patients and clinicians)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The University of Texas Health Science Center, Houston

Registry

ClinicalTrials.gov

Start date

25 June 2024

Est. completion

31 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Head and neck cancer (HNC) symptoms as assessed by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires (QLQ)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov